Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
03/14/1991 | DE3930206A1 Hypolipaemic pharmaceutical prods. - comprising combination of cholestyramine and drug of vibrate type |
03/14/1991 | DE3930168A1 Pharmaceutical compsn. contg. colestyramine to reduce lipid - in micro:tablet form levels without unpleasant taste |
03/14/1991 | CA2025162A1 Non-effervescent ibuprofen compositions |
03/13/1991 | EP0416951A1 Medicaments comprising salmeterol and fluticason |
03/13/1991 | EP0416842A1 Solid matrix system for transdermal drug delivery |
03/13/1991 | EP0416837A1 Photoprotection compositions having reduced dermal irritation |
03/13/1991 | EP0416804A1 External preparation containing amusulosin |
03/13/1991 | EP0416773A2 Vitamin B12 composition |
03/13/1991 | EP0416739A1 Pharmaceutical compositions containing penciclovir |
03/13/1991 | EP0416722A2 Pharmaceutical compositions having differential drug release rate |
03/13/1991 | EP0416698A1 Contrast media |
03/13/1991 | EP0416678A1 Topical compositions containing Defibrotide |
03/13/1991 | EP0416677A1 Compositions for topical cosmetic use containing depolymerized nucleic acids |
03/13/1991 | EP0416575A2 Drug delivery compositions based on biological materials and methods for preparing such compositions |
03/13/1991 | EP0416527A2 Prostaglandin-containing liposome preparations |
03/13/1991 | EP0416232A2 Stable injectable pharmaceutical formulation for folic acid and leucovorin salts and method |
03/13/1991 | EP0416137A1 Method for reducing skin irritation associated with drug/penetration enhancer compositions |
03/13/1991 | EP0416011A1 Chemotherapeutic composition for aids |
03/13/1991 | EP0415999A1 Compositions having use as treatment of psoriasis and neuropsychiatric deficits |
03/13/1991 | EP0415922A1 Integrity protected gelatin |
03/13/1991 | CN1049787A Gastric retention device |
03/12/1991 | WO1991003491A1 TGF-β PROTEIN COMPOSITIONS FOR INHIBITION OF CELL PROLIFERATION |
03/12/1991 | US4999435 Cationic Surfactants, Drugs, Immunoassay |
03/12/1991 | US4999417 Biodegradable polymer compositions |
03/12/1991 | US4999379 Novel pharmaceutical compositions for topical application with systemic action |
03/12/1991 | US4999375 Psoralen reagent compositions for extracorporeal treatment of blood |
03/12/1991 | US4999348 Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions |
03/12/1991 | US4999344 Phosphatidyl treatment of rapidly proliferating cells |
03/12/1991 | US4999342 Long lasting contraceptive suppository composition and methods of use |
03/12/1991 | US4999226 Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination |
03/12/1991 | US4999200 Wetting, binding, and disintegration agents; laxative tablet |
03/12/1991 | US4999199 Pharmaceutical formulations: liposomes incorporating aromatic polyene antibiotics |
03/12/1991 | US4999198 Polyaphrons as a drug delivery system |
03/12/1991 | US4999189 Sustained release oral suspensions |
03/12/1991 | US4999188 Methods for embolization of blood vessels |
03/12/1991 | US4999185 Cacao Husk Extract |
03/12/1991 | CA2066228A1 Tgf-beta protein compositions for inhibition of cell proliferation |
03/12/1991 | CA2024965A1 Preventive and therapeutic agent for hepatitis |
03/12/1991 | CA2024939A1 Device for the continuous release of vitamin a in drinking water |
03/12/1991 | CA2024887A1 Pharmaceutical preparations |
03/12/1991 | CA1281289C Ultradense and more soluble and bioavailable preparation of calcium citrate |
03/10/1991 | WO1991003249A1 Preparations containing colestyramine for reducing lipid levels |
03/10/1991 | CA2065151A1 Preparations containing colestyramine for reducing lipid levels |
03/09/1991 | WO1991003219A1 Solid matrix system for transdermal drug delivery |
03/09/1991 | CA2024884A1 Photoprotection compositions having reduced dermal irritation |
03/08/1991 | CA2024804A1 Prostaglandin-containing liposome preparations |
03/08/1991 | CA2021874A1 Pharmaceutical composition for topic use for the therapeutical treatment of capillary fragility |
03/07/1991 | WO1991003099A1 Compressed powder medicaments |
03/07/1991 | WO1991002763A1 Polymeric materials |
03/07/1991 | WO1991002543A1 Stabilized vaccine compositions |
03/07/1991 | WO1991002532A2 Method for stimulating fibrinolytic effect |
03/07/1991 | WO1991002519A1 Method for increasing the pharmaceutical effect of inositol phosphate and a composition with improved pharmaceutical effect |
03/07/1991 | WO1991002518A1 Pharmaceutical compositions and a device for administering the same |
03/07/1991 | DE4027143A1 Stabilising blood substitute emulsions contg. per:fluoro-hydrocarbon |
03/07/1991 | DE4019062A1 Stabilising blood substitute emulsions contg. per:fluoro-hydrocarbon |
03/07/1991 | DE4019061A1 New and known perfluorinated N-cycloalkyl cyclic amine derivs. |
03/07/1991 | DE3929184A1 Oral dosage forms for angina treatment - contg. iso:sorbide di:nitrate |
03/07/1991 | CA2065023A1 Stabilized vaccine compositions |
03/07/1991 | CA2064882A1 Pharmaceutical compositions and a device for administering the same |
03/06/1991 | WO1991003271A1 Apparatus for administering medicaments to mucosal tissue |
03/06/1991 | WO1991003237A1 Compositions and methods of manufacture of oral dissolvable medicaments |
03/06/1991 | WO1991003236A1 Transmucosal dosage form |
03/06/1991 | EP0415671A2 Gastric retention device |
03/06/1991 | EP0415656A2 Production of sorbitol coated comestible |
03/06/1991 | EP0415522A1 Process for reducing the crystal size of ondansetron hydrochloride dihydrate |
03/06/1991 | EP0415458A2 Use of retinoids for preventing and reducing the size of striae distensae lesions |
03/06/1991 | EP0415430A1 Stable solutions of mitomycin C |
03/06/1991 | EP0415326A1 Composition for foaming preparation |
03/06/1991 | EP0415264A2 Process for the preparation of perfluorinated heterocyclic compounds and compounds prepared by this process |
03/06/1991 | EP0415263A2 Stabilisation of perfluorocarbon emulsions and perfluorinated heterocyclic compounds usable as emulsion stabilising additives |
03/06/1991 | EP0415087A1 Tampon for medical or hygienic purposes and its method of manufacture |
03/06/1991 | EP0415055A2 Water-soluble pressure-sensitive skin adhesive |
03/06/1991 | EP0414932A1 Chewing gum composition |
03/06/1991 | EP0414920A1 Aerosol preparation for external use |
03/06/1991 | EP0414815A1 Blood substitute |
03/06/1991 | EP0414806A1 High ratio active agent:lipid complex. |
03/06/1991 | EP0414757A1 An agent for desensitizing man and/or animals against an allergen |
03/06/1991 | EP0414730A1 Luminide and macroluminide class of pharmaceuticals |
03/06/1991 | EP0414663A1 Liposome continuous size reduction method and apparatus |
03/06/1991 | CN1049593A Improved sorbitol coated comestible and method of preparation |
03/06/1991 | CA2024587A1 Drug delivery compositions based on biological cells or components thereof and methods |
03/05/1991 | WO1991003263A1 Contrast media |
03/05/1991 | US4997904 Aromatic polyanhydride compositions |
03/05/1991 | US4997856 Method of producing compacted dispersable systems |
03/05/1991 | US4997819 Pullulan, amylopectin, or dextrin |
03/05/1991 | US4997761 Phosphatidyl treatment of viral disease |
03/05/1991 | US4997658 Method for enhancing the lowering of plasma cholesterol levels |
03/05/1991 | US4997656 Adhesive for percutaneous administration |
03/05/1991 | US4997655 Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same |
03/05/1991 | US4997654 Method for increasing salivation for xerostomia patients |
03/05/1991 | US4997653 Method for treating endometriosis with topical preparations containing danazol |
03/05/1991 | US4997652 Drug delivery |
03/05/1991 | US4997651 Pharmaceutical formulations |
03/05/1991 | US4997643 Polymeric salt delivery systems |
03/05/1991 | US4997454 Precipitation |
03/05/1991 | US4997443 Reversible gel polymer |
03/05/1991 | CA2064880A1 Contrast media |
03/05/1991 | CA2024438A1 External preparation containing amusulosin |
03/05/1991 | CA1280977C Polyprenyl alcohol-containing injections |
03/05/1991 | CA1280976C Process for the preparation of solid nifedipine formulations of high bioavailability and with sustained effect, and formulations thusobtained |